Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Docetaxel and S-1 in Breast Cancer
NCT00994968Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur-gimeracil-oteracil in breast cancer, sponsored by Yonsei University. Status: unknown.
02
Drugs
tegafur-gimeracil-oteracil
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00994968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00994968.